Surgical compositions for reducing the incidence of adhesions
Patent 8063027 Issued on November 22, 2011. Estimated Expiration Date: October 25, 2025. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
A method of preventing or reducing the incidence of post-operative adhesions in or associated with a body cavity, which comprises introducing into the body cavity a composition containing an aqueous solution or suspension or gel formulation containing the polysaccharide dextrin.
English Language Translation, Official Action, Japanese Patent Application No. 200-548018, Jul. 18, 2003.
ML Laboratories, “Adhesions” PanMureGordon (Mar. 20, 1998).
U.S. Appl. No. 11/566,849, filed Dec. 5, 2006, Brown et al.
Treutner et al. “Prevention of Postoperative Adhesions by Single Intraperitoneal Medication” Journal of Surgical Research 59:764-771 (1995).
Harris et al. “Analysis of the kinetics of peritoneal adhesion formation in the rat and evaluation of potential antiadhesive agents” Surgery 117(6):663-669 (2005).
Dobbie, J.W. (1997) “Separation of Peritoneal Surfaces Through the Maintenance of an Artificial Ascites as a Preventative of Peritoneal Adhesions.” Abstract, from The 4th Peritoneum and Peritoneal Access Meeting, Sep. 16-19, 1997.